Results 11 to 20 of about 136,885 (362)

Controlling secretion to limit chemoresistance [PDF]

open access: yesGenes & Development, 2016
The tumor microenvironment influences cancer progression and therapy outcome by mechanisms not yet fully understood. In this issue, Bent et al. (2016) show how chemotherapy causes endothelial senescence.
Georgilis, A, Gil, J
core   +6 more sources

KLF4 in cancer chemoresistance: molecular mechanisms and therapeutic implications [PDF]

open access: goldDiscover Oncology
Chemoresistance is a major obstacle in cancer treatment, and it often results in treatment failure and disease progression. Among the plethora of factors contributing to chemoresistance, the transcription factor Krüppel-like factor 4 (KLF4) has emerged ...
Suresh Singh Yadav   +6 more
doaj   +2 more sources

Mitochondrial determinants of chemoresistance [PDF]

open access: yesCancer Drug Resistance, 2019
Chemoresistance constitute nowadays the major contributor to therapy failure in most cancers. There are main factors that mitigate cell response to therapy, such as target organ, inherent sensitivity to the administered compound, its metabolism, drug efflux and influx or alterations on specific cellular targets, among others. We now know that intrinsic
Bokil, Ansooya, Sancho, Patricia
openaire   +2 more sources

Exosomal miR-331 from Chemoresistant Osteosarcoma Cells induced Chemoresistance through Autophagy [PDF]

open access: yes, 2021
Abstract BackgroundOsteosarcoma (OS) is a highly malignant tumor. Improving chemotherapeutic resistance is very important to improve the survival rate of OS. Exosomes and microRNAs (MiRNA) play important roles in the mechanism of chemotherapeutic resistance transmission. More and more researches focus the mechanism of miRNAs carried by exosomes
Aiqing Zhao   +8 more
openaire   +2 more sources

Clusterin and Chemoresistance [PDF]

open access: yes, 2009
Resistance to anticancer agents is one of the primary impediments to effective cancer therapy. Chemoresistance occurs not only to clinically established therapeutic agents but also to novel targeted therapeutics. Both intrinsic and acquired mechanisms have been implicated in drug resistance but it remains controversial which mechanisms are responsible ...
Julie Y, Djeu, Sheng, Wei
openaire   +2 more sources

Apoptosis and melanoma chemoresistance [PDF]

open access: yesOncogene, 2003
Melanoma is the most aggressive form of skin cancer and is notoriously resistant to all current modalities of cancer therapy. A large set of genetic, functional and biochemical studies suggest that melanoma cells become 'bullet proof' against a variety of chemotherapeutic drugs by exploiting their intrinsic resistance to apoptosis and by reprogramming ...
María S, Soengas, Scott W, Lowe
openaire   +2 more sources

Chemoresistance in Pancreatic Cancer [PDF]

open access: yesInternational Journal of Molecular Sciences, 2019
Pancreatic ductal adenocarcinoma (PDAC), generally known as pancreatic cancer (PC), ranks the fourth leading cause of cancer-related deaths in the western world. While the incidence of pancreatic cancer is displaying a rising tendency every year, the mortality rate has not decreased significantly because of late diagnosis, early metastasis, and limited
Siyuan Zeng   +5 more
openaire   +2 more sources

Biomimetic gold nanocages for overcoming chemoresistance of osteosarcoma by ferroptosis and immunogenic cell death

open access: yesMaterials & Design, 2021
Chemoresistance remains a huge challenge for the treatment of osteosarcoma (OS). Multiple mechanisms are involved in chemoresistance of cisplatin.
Chong Zhang   +6 more
doaj   +1 more source

Endoglin Is Essential for the Maintenance of Self-Renewal and Chemoresistance in Renal Cancer Stem Cells. [PDF]

open access: yes, 2017
Renal cell carcinoma (RCC) is a deadly malignancy due to its tendency to metastasize and resistance to chemotherapy. Stem-like tumor cells often confer these aggressive behaviors.
Dai, Jin   +10 more
core   +3 more sources

Chemotherapy‐induced release of ADAM17 bearing EV as a potential resistance mechanism in ovarian cancer

open access: yesJournal of Extracellular Vesicles, 2023
Ovarian cancer (OvCa) is the gynaecological disorder with the poorest prognosis due to the fast development of chemoresistance. We sought to connect chemoresistance and cancer cell‐derived extracellular vesicles (EV).
Gerrit Hugendieck   +16 more
doaj   +1 more source

Home - About - Disclaimer - Privacy